Nanox Expands Latin American Reach with Costa Rica Distribution Agreement for Nanox.ARC

Nanox Imaging Ltd. (NASDAQ: NNOX) has entered into a distribution agreement with SOLME RC, S.A., a Costa Rica-based medical equipment distributor, to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement positions Nanox to penetrate Costa Rica's public healthcare market, as SOLME RC is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. This move represents Nanox's third Latin American market this year, following Argentina and Peru, underscoring the company's strategic focus on expanding its footprint in emerging markets.

The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system intended for ease of use and scalability. It is part of the broader Nanox ecosystem, which includes Nanox.AI, a suite of AI-based algorithms for CT imaging; Nanox.CLOUD, a cloud-based platform for data management and analytics; and Nanox.MARKETPLACE, which provides access to remote radiology and teleradiology services. By integrating these components, Nanox aims to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The distribution agreement with SOLME RC will cover marketing, distribution, installation, training, and ongoing technical support in Costa Rica. Commercialization will proceed after applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration.

This agreement is significant because it highlights Nanox's ability to execute its global expansion strategy, particularly in regions where access to advanced medical imaging is limited. Costa Rica's public healthcare system, managed by the CCSS, serves a population of approximately 5 million people. By partnering with a well-established local distributor like SOLME RC, Nanox can navigate regulatory hurdles and build relationships with key stakeholders. The proof-of-concept registration period allows for real-world validation of the Nanox.ARC in a clinical setting, which could facilitate broader adoption across Latin America. Moreover, the agreement follows Nanox's recent entries into Argentina and Peru, demonstrating a consistent push into Spanish-speaking markets where the company sees potential for its affordable imaging solutions.

For investors, this news signals progress in Nanox's commercialization efforts. The company's vision is to drive the world's transition to preventive healthcare by delivering an integrated, end-to-end medical imaging and healthcare services platform. The Nanox.ARC is central to this vision, as it is designed to be more accessible and affordable than traditional CT and MRI systems. By expanding into Costa Rica, Nanox not only increases its addressable market but also gathers valuable data and experience that can inform further expansion. The agreement with SOLME RC also leverages local expertise and infrastructure, reducing the risks associated with entering a new market.

In the broader context, Nanox's expansion into Latin America aligns with global trends toward decentralized healthcare and early disease detection. The COVID-19 pandemic has accelerated the adoption of remote and point-of-care imaging solutions, and Nanox is well-positioned to capitalize on this shift. However, challenges remain, including regulatory approvals, reimbursement, and competition from established imaging vendors. The successful deployment of the Nanox.ARC in Costa Rica could serve as a proof point for other countries in the region and beyond. For more details, refer to the full press release at https://ibn.fm/C77lJ and the company's newsroom at http://ibn.fm/NNOX.